Natriuretic Peptides in Chronic Heart Failure
Normal brain natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) levels are helpful in excluding chronic heart failure in the ambulatory setting, although they have been studied less well and possibly less accurately than in acute care. They may also be of help in screening patients at risk...
Guardado en:
Autores principales: | Hans-Peter Brunner-La Rocca, Sandra Sanders-van Wijk |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/57768560db9c46f5a594691b34c910ef |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PRospective Evaluation of natriuretic peptide-based reFERral of patients with chronic heart failure in primary care (PREFER): a real-world study
por: Yigal M Pinto, et al.
Publicado: (2021) -
Evaluation of the Effect of Heart Failure Reversal Therapy on Exercise Capacity in Patients with Chronic Heart Failure and the Association with Co-morbidities
por: R Sane
Publicado: (2020) -
Interatrial Shunting for Treating Acute and Chronic Left Heart Failure
por: Leonardo Guimaraes, et al.
Publicado: (2020) -
Evaluation of the Effect of Heart Failure Reversal Therapy on Anthropometric Obesity Parameters in Patients with Chronic Heart Failure: A Retrospective Analysis
por: R Sane
Publicado: (2020) -
Clinical Characteristics of De Novo Heart Failure and Acute Decompensated Chronic Heart Failure: Are They Distinctive Phenotypes That Contribute to Different Outcomes?
por: Wilson Matthew Raffaello, et al.
Publicado: (2021)